Gemcitabine Hydrochloride for Injection 1g (1vial/box)

Product Details
Customization: Available
Dosage Form: Powder Injection
Transport Package: Carton
Still deciding? Get samples of US$ 0.1/Piece
Request Sample
Manufacturer/Factory, Trading Company, Group Corporation
Gold Member Since 2018

Suppliers with verified business licenses

Audited Supplier

Audited by an independent third-party inspection agency

Importers and Exporters
The supplier has import and export rights
to see all verified strength labels (7)
  • Gemcitabine Hydrochloride for Injection 1g (1vial/box)
  • Gemcitabine Hydrochloride for Injection 1g (1vial/box)
  • Gemcitabine Hydrochloride for Injection 1g (1vial/box)
  • Gemcitabine Hydrochloride for Injection 1g (1vial/box)
  • Gemcitabine Hydrochloride for Injection 1g (1vial/box)
Find Similar Products

Basic Info.

Model NO.
Powder Injection
Specification
1g
Trademark
Sinolead
Origin
China

Product Description

Gemcitabine Hydrochloride for Injection 1g (1vial/box)Gemcitabine Hydrochloride for Injection 1g (1vial/box)
Basic Info.

 
Generic Name Gemcitabine Hydrochloride for Injection 1g
Strength 1g
Packing 1vial/box
Origin China

Component:
Gemcitabine Hydrochloride.

Character:
This product is white loose mass.

Indications:

This product can be used to treat the following diseases:
- Locally advanced or metastatic non-small cell lung cancer;
-- Locally advanced or metastatic pancreatic cancer;
Gemcitabine in combination with paclitaxel is indicated for the treatment of unresectable, locally recurrent or metastatic breast cancer that has recurred after adjuvant/neoadjuvant chemotherapy. Anthracyclines should have been used in previous chemotherapy unless clinically contraindicated.

 

Usage and dosage:

This product should be used under the guidance of an experienced oncologist. It is recommended to refer to existing clinical trial data and adjust the dosage according to individual clinical conditions.

dose

Adult:

Non-small cell lung cancer

Monotherapy:

The recommended dose of gemcitabine is 1000mg/m2 intravenously for 30 minutes. After 3 weeks of treatment, rest for 1 week and repeat the above 4-week treatment cycle. Depending on the patient's tolerance to gemcitabine, a dose reduction may be considered per treatment cycle or within one treatment cycle.

Combination therapy:

Gemcitabine combined with cisplatin has two treatment options: 3-week therapy and 4-week therapy.

3-week therapy: The recommended dose of gemcitabine is 1250mg/m2 for 30 minutes intravenously. Dosing was given on day 1, day 8, and day 15 of every 28-day treatment cycle. Depending on the patient's tolerance to gemcitabine, a dose reduction may be considered per treatment cycle or within one treatment cycle.


Precautions:

Liver insufficiency

Gemcitabine given to patients who have already developed liver metastases or who have a history of hepatitis, alcoholism, or cirrhosis may worsen underlying liver dysfunction.

Laboratory evaluations of kidney and liver function, including virological tests, should be performed regularly.

Because there is not enough information from clinical studies on clear dose recommendations for these patient populations, gemcitabine should be used with caution in patients with liver insufficiency or renal impairment, as clinical studies in these patients do not have sufficient data to make a clear dose recommendation.

 

Gemcitabine Hydrochloride for Injection 1g (1vial/box)Gemcitabine Hydrochloride for Injection 1g (1vial/box)Gemcitabine Hydrochloride for Injection 1g (1vial/box)Gemcitabine Hydrochloride for Injection 1g (1vial/box)


 

Send your message to this supplier

*From:
*To:
*Message:

Enter between 20 to 4,000 characters.

This is not what you are looking for? Post a Sourcing Request Now
Contact Supplier